Cedars-Sinai Pulse Newsletter - Aug. 20, 2010 Issue

Physician News

Michael Alexander, M.D., ...

Stephen A. Geller, M.D., ...

Mark Goodarzi, M.D., Ph.D., ...

FDA Proposes Withdrawal of Midodrine

Pharmacy Focus

The U.S. Food and Drug Administration proposed to withdraw marketing approval of midodrine, a drug used to treat low blood pressure. The administration also issued a "notice of opportunity for a hearing" to the companies that manufacture midodrine.

» Read more

Meetings and Events

High Holiday Services – Sept. 9, 17, 18

Rehabilitation Topics on the Neurological and Neurovascular Treatment of Stroke – Sept. 11

Politics and PBS: What You Don't See on TV – Sept. 24

» Read more

In This Issue:

Heart Institute Opens California's First Advanced Heart Failure Inpatient Unit

The Cedars-Sinai Heart Institute has opened an innovative 30-bed inpatient unit dedicated to providing advanced heart failure patients with an intensive, multidisciplinary approach to inpatient care. The unit on 6 South East formally opened late last month.

» Read more

Drug reduces tumor size in ovarian, breast cancer patients

Research Corner

An international consortium of researchers that included William Audeh, M.D., of Cedars-Sinai has shown that an investigational drug can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations.

» Read more